Cargando…
Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
Despite the recent advances in the development of antitumor therapies, the prognosis for patients with malignant gliomas remains dismal. Therapy with tumor-selective viruses is emerging as a treatment option for this devastating disease. In this study we characterize the anti-glioma effect of VCN-01...
Autores principales: | Vera, Beatriz, Martínez-Vélez, Naiara, Xipell, Enric, Acanda de la Rocha, Arlet, Patiño-García, Ana, Saez-Castresana, Javier, Gonzalez-Huarriz, Marisol, Cascallo, Manel, Alemany, Ramón, Alonso, Marta M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726573/ https://www.ncbi.nlm.nih.gov/pubmed/26808201 http://dx.doi.org/10.1371/journal.pone.0147211 |
Ejemplares similares
-
Correction: Characterization of the Antiglioma Effect of the Oncolytic Adenovirus VCN-01
por: Vera, Beatriz, et al.
Publicado: (2016) -
The oncolytic adenovirus VCN-01 promotes anti-tumor effect in primitive neuroectodermal tumor models
por: Garcia-Moure, Marc, et al.
Publicado: (2019) -
Phase I, multicenter, open-label study of intravenous VCN-01 oncolytic adenovirus with or without nab-paclitaxel plus gemcitabine in patients with advanced solid tumors
por: Garcia-Carbonero, Rocio, et al.
Publicado: (2022) -
VCN-01 disrupts pancreatic cancer stroma and exerts antitumor effects
por: Bazan-Peregrino, Miriam, et al.
Publicado: (2021) -
Analysis of SOX2-Regulated Transcriptome in Glioma Stem Cells
por: Acanda de la Rocha, Arlet M., et al.
Publicado: (2016)